MedTrace Logo

MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use

NCT02744313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2018-07-31

No results posted yet for this study

Summary

This study will focus on a population of antipsychotic (AP) naïve adolescents and young adults and will measure fat accumulation in relation to exposure to atypical antipsychotic medications.

Conditions

  • Adiposity

Sponsors & Collaborators

  • American Academy of Child Adolescent Psychiatry.

    collaborator OTHER

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Margaret Hahn, MD, PhD · Centre for Addiction and Mental Health

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02744313 on ClinicalTrials.gov